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Abstract: The seed extract (GSE) of Burgund Mare de Recas grape variety was evaluated for antitumor 
activity against Ehrlich ascites carcinoma(EAC)-bearing Swiss albino mice. The antioxidant activity of GSE was 
also estimated in EAC-bearing mice treated with doxorubicin 2x0.1 mg/mouse. The composition in polyphenols 
of the GSE, expressed as gallic acid,  consisted of 11.477mg/l.  The anti-tumor activity of GSE was assessed by 
measuring the tumor volume and by counting the tumor cells. As oxidative stress parameters the total 
thiobarbituric reactive reactive substances (TBARS) in the plasma were measured. The results indicate that GSE 
does not dot possess antitumor activity against Ehrlich ascitic carcinoma cells, does not interfere with the 





Cancer is one of the most frequent neoplastic diseases in human population and one of 
the most frequent causes of death. There are a lot of pathological factors, including reactive 
oxygen species (ROS) involved in the process of cancer initiation, promotion  and progression 
(1). First, an oxidative stress can induce DNA damages that lead to genomic instability and 
possibly stimulate cancer progression (2). Second, elevated ROS levels are responsible for 
constant activation of transcription factors and the progression of the disease(3). For these 
reasons, the search for antioxidants as cancer chemopreventive agents is a continued process. 
Another aspect of antioxidant administration in cancer patients is that these could affect 
antineoplastic efficacy or the development of side effects of anticancer drugs (4).  A number 
of studies indicate that plant derived natural products, such as polyphenols, possess diverse 
pharmacological properties, among which antioxidant activity (5,6). The aim of the present 
study was to evaluate the antitumor and the antioxidant activity of the seed extract of Burgund 
Mare de Recas grape variety against Ehrlich ascitic carcinoma cells. 
 
MATERIALS AND METHODS 
 
Materials 
Doxorubicin: the dose used in the experiment was 2x0.1 mg/mouse (7). 
Grape seed extract: the powder of the seeds of Burgund Mare de Recas grape variety 
was provided by Department of Viticulture, University of Agricultural Sciences and 
Veterinary Medicine, Cluj-Napoca. The grape seed extract (GSE) was prepared in the 
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Laboratory of Tumor Biology, “I.Chiricuta” Cluj-Napoca, stored at 4°C in light-tight 
containers until used and diluted with 0.5% carboxymethylcelullose when used. The 
composition in polyphenols of the GSE, expressed as gallic acid equivalents,  consisted of 
11.477mg/l.   
Animals and treatment 
Male Swiss albino mice, with an average body weight of 20± 2g were used in the 
experiment. The animals were housed at a room temperature of 23±2 0 C, with a 12/12 hours 
light/dark cycle, with food and water ad libitum. They were allowed to acclimate for 1 week 
prior to experimental procedures. Mice were inoculated with 1x106 EAC in the day 0 of the 
experiment (8). 
Tumor cells 
Ehrlich ascites carcinoma (EAC) cells were obtained from the Laboratory of 
Experimental Pathology, “I.Chiricuta” Oncological Institute Cluj-Napoca. The EAC cells 
were maintained in vivo in Swiss albino mice, by intraperitoneal (i.p.) transplantation of 
1x106 cells/mouse every 10 days (9). 
Experimental protocol 
Male Swiss albino mice were divided into 5 groups of 10 animals (n=10) each, as 
follows: 
Group I (controls): EAC-bearing mice 
Group II: EAC-bearing mice which were treated with doxorubicin (dox) i.p. the days 
+1 and +4 of the experiment 
Group III: EAC bearing mice which were given GSE i.p. in the days 0, +1 and +4 of 
the experiment 
Group IV: EAC-bearing mice treated with doxorubicin i.p. in the days +1 and +4 and 
with GSE i.p. in the days 0, +1 and +4 of the experiment 
Group V: EAC bearing mice which were given only the vehicle 
(carboxymethylcelullose 0.5%) i.p. in the days 0, +1 and +4 of the experiment 
On the day +11 all mice were killed by cervical dislocation; blood samples were 
collected and the plasma quickly separated and frozen at -80OC until used. The anti-tumor 
activity of GSE was measured in EAC bearing mice with respect to the following 
parameters(10):  
tumor volume. The mice were dissected and the ascitic fluid was collected from the 
peritoneal cavity. The volume of the fluid was measured by taking it in a graduated centrifuge 
tube. 
tumor cell count. The ascitic fluid was diluted 1:10-1:15 and the cells were counted in 
a Burker counting chamber. The non-viable cells, as estimated by staining with trypan blue, 
were not counted. 
Estimation of oxidative stress parameters 
   As oxidative stress parameters in plasma we determined the level of lipid peroxides 
(11), which result from interaction of free radicals with unsaturated lipids, and which are 
bound to lipoproteins, and the level of free malonaldehyde (12), which is a product of 
decomposition of oxidized lipids in plasma. The amount of oxidation products was expressed 
as thiobarbituric reactive substances (TBARS), which represents the sum of lipid peroxides 
and free malonaldehyde, as nmol/ml plasma.  
 
RESULTS AND DISCUTIONS 
 
The tumor volume and the total EAC cells in the 5 study groups are presented in Tab.I. 
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Group I controls 2.67±1.39 350.35±234.84 
Group II doxorubicin 2.16±1.40 26.68±17.87* 
Group III GSE 1.64±0.67 164.40±114.48 
Group IV doxorubicin+GSE 1.55±0.33 76.25±37.75 
Group V vehicle 2.83±0.88 424.20±102.72 
* p<0.05   
 
In the present study, doxorubicin demonstrates a marked antitumor effect in mice 
inoculated with Ehrlich tumor cells. To et al. (13) also reported the antitumor  properties of the 
anthracycline against Ehrlich carcinoma cells.  The results are not surprisingly, as doxorubicin 
rank among the most effective anticancer drugs ever developed, possessing significant activity 
against solid and hematologic malignancies (14). Regarding  the antitumor effects of 
polyphenols, studies in the literature show various results, depending on the experimental 
model and the source of polyphenols used. It was reported that the nonhydroxylated core 
structure of the flavones, flavone, induce programmed cell death and growth inhibiton in 
cancer cell lines (15). Nyska et al. (16) also reported that NAO, a mixture of mainly aromatic 
polyphenols and flavonoids, but not epigallocatechin-3-gallate, was effective in slowing the 
spontaneous prostatic carcinogenic process in some rodent models of carcinogenesis. It was 
suggested that resveratrol, a polyphenolic compound, has antitumor activity in cell culture, but 
weak antileukemic effect in mice injected with leukemic cells (17). In our in vivo model, even 
it was noted a tendency of reduction of tumor cell number for GSE alone, the difference was 
not significant, leading us to the conclusion that GSE doesn’t demonstrate antitumor activity. 
The mechanisms of action of doxorubicin are multiple. First of all, it forms a covalent 
complex with DNA-topoisomerase, thus preventing the activation of this enzyme. Secondly, 
doxorubicin intercalates in the DNA bone and leads to single or double strand breaks. Thirdly, 
hepatic metabolism of the drug leads to production of oxygen reactive species, which, in turn,  
damage DNA and cause cell death (14). Indeed, in our study, as shown in Fig.1, the levels of 
plasma lipid peroxidation were significantly higher in EAC-bearing mice treated with 
doxorubicin than in those untreated. On the contrary, plasma levels of lipid peroxidation 
products in EAC-bearing mice did not differ in GSE or vehicle treated animals as compared to 
controls (Fig. 2). 
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One problem preventing more widespread of anthracyclines use has been the 
development of side effects. Experimental evidence supports oxidant stress as an important 
trigger and/or mediator of doxorubicin-induced cardiotoxicity (18), hence the attempts which 
were made to attenuate the oxidative stress by the mean of antioxidants(19). In this respect, a 
number of studies demonstrated the antioxidant effects of plant polyphenols in animal models 
(5,6). The results of the present study indicate that in EAC-bearing Swiss albino mice treated 
with doxorubicin, GSE lowered significantly the plasma levels of lipid peroxidation products, 
as shown in Fig.3.       
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Fig.3. Plasma TBARS in doxorubicin and GSE treated mice as 
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A problem raised by the use of antioxidant in cancer patients is that if generation of 
ROS by a cancer chemoterapeutic agent or a free radical intermediate of the drug plays a role 
in its cytotoxicity, antioxidants may interfere with the drug’s neoplastic activity (4). Our 
results (Tab.I)suggest that GSE reduces the oxidative effects of doxorubicin, without 




GSE (Burgund Mare de Recas) does not demonstrate antitumor activity against Ehrlich 
ascitic carcinoma cells 
GSE decreases the lipid peroxidation induced by doxorubicin treatment 
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